Nathan J Dowden is President & COO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 125,149 shares of TRDA, which is worth approximately $2.2 Million. The most recent transaction as insider was on Oct 20, 2022, when has been sold 905 shares (Common Stock) at a price of $18.07 per share, resulting in proceeds of $16,353. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0.67% 3M change
159.82% 12M change
Total Value Held $2.2 Million

Nathan J Dowden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2022
SELL
Open market or private sale
$16,353 $18.07 p/Share
905 Reduced 1.44%
61,906 Common Stock
Sep 26 2022
SELL
Open market or private sale
$24,380 $15.79 p/Share
1,544 Reduced 2.4%
62,811 Common Stock
Sep 23 2022
SELL
Open market or private sale
$15,341 $15.07 p/Share
1,018 Reduced 1.56%
64,355 Common Stock
Sep 21 2022
SELL
Open market or private sale
$49,551 $15.13 p/Share
3,275 Reduced 4.77%
65,373 Common Stock
Sep 15 2022
SELL
Open market or private sale
$1,501 $15.01 p/Share
100 Reduced 0.15%
68,648 Common Stock
Sep 09 2022
SELL
Open market or private sale
$13,027 $15.06 p/Share
865 Reduced 1.24%
68,748 Common Stock
Sep 08 2022
SELL
Open market or private sale
$13,817 $15.15 p/Share
912 Reduced 1.29%
69,613 Common Stock
Sep 01 2022
BUY
Grant, award, or other acquisition
-
5,632 Added 7.4%
70,525 Common Stock
Jun 27 2022
SELL
Open market or private sale
$100,282 $13.0 p/Share
7,714 Reduced 10.62%
64,893 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
11,263 Added 13.43%
72,607 Common Stock
NJD

Nathan J Dowden

President & COO
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA